
CDMO services
Formulation Development
Complex oral solid dosage forms, developed with more than one technology solution for every challenge.
Overview
From difficult molecule to robust, scalable formulation
Our formulation development group focuses on immediate and controlled release oral solids that are complex in nature and present competitive barriers to entry. The breadth of our technology platforms means we can offer more than one solution to any drug formulation challenge.
Development programmes are supported by in-house analytical method development, stability studies and regulatory expertise, so that what works in the laboratory is ready for commercial scale.
- Feasibility assessment and prototype screening
- Robust, scalable processes designed for commercial manufacture
- Stability studies and analytical validation
- Full documentation for regulatory submission
Platforms
We recommend the following
Immediate Release Dosage Forms
Conventional tablets and capsules with rapid, reliable dissolution.
Bioavailability Enhancement
Technologies that improve absorption for poorly soluble actives.
Orally Disintegrating Tablets
Fast-dispersing tablets for patients who struggle with swallowing.
Taste Masking
Palatable formulations for sensitive or bitter active ingredients.
Controlled Release Technologies
Precise release profiles tailored to clinical need.
Sustained Release
Release engineered over 8 to 24 hours for once- or twice-daily dosing.
Zero Order Release
Constant drug release rates independent of time.
Delayed Release
Enteric and site-specific release for targeted delivery.
Pulsatile Release
Programmed, time-controlled multi-dose release.
Chrono Release
Release aligned to the body's circadian rhythms.
How we work
A disciplined development pathway
Brief & feasibility
We review your molecule, target product profile and regulatory strategy, then confirm feasibility and risks.
Prototype development
Screening trials identify the formulation platform and prototype that best meets the target profile.
Analytical development
Methods are developed and validated, with stability programmes designed around your submission plan.
Scale-up & exhibit batches
Processes are transferred to our cGMP facility for scale-up, exhibit and registration batches.
Regulatory support
Complete development and manufacturing documentation supports your filing and inspection needs.
Start a programme
Challenge us with your formulation
Send us your molecule and target product profile — we will respond with a development route and timeline.